Andrew Berens
Stock Analyst at Leerink Partners
(4.86)
# 358
Out of 4,453 analysts
539
Total ratings
48%
Success rate
24.1%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Reiterated: Buy | n/a | $6.86 | - | 28 | Jun 2, 2026 | |
| STRO Sutro Biopharma | Rated: Buy | $38 → $43 | $29.55 | +45.52% | 2 | May 15, 2026 | |
| TNGX Tango Therapeutics | Rated: Buy | $10 → $55 | $30.14 | +82.48% | 26 | May 15, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 → $33 | $19.40 | +70.10% | 14 | May 15, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $46 → $51 | $22.57 | +125.96% | 2 | May 15, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $7 → $11 | $2.07 | +431.40% | 26 | Apr 27, 2026 | |
| ANL Adlai Nortye | Initiated Coverage: Buy | $23 | $10.16 | +126.38% | 1 | Mar 20, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $41 | $7.69 | +433.16% | 3 | Mar 6, 2026 | |
| RLMD Relmada Therapeutics | Initiated Coverage: Buy | $8 | $6.45 | +24.03% | 1 | Jan 23, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | $34 → $40 | $36.20 | +10.50% | 51 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $40 | $23.77 | +68.28% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $97 | $95.93 | +1.12% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $149 | $123.53 | +20.62% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $38.01 | +31.56% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.53 | +231.13% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $48 | $53.23 | -9.83% | 12 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $36.29 | -9.07% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.48 | - | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $4.22 | +681.99% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $17.83 | -32.70% | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $2.51 | +19.52% | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $275.34 | +25.30% | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $8.03 | +12.08% | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.79 | +31.93% | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 | $9.81 | +83.49% | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $103 | $107.53 | -4.21% | 61 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $142.94 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $64.43 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 → $25 | $4.40 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $21.66 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.51 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $7.67 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $108.26 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $8 | $9.76 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.6508 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.04 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $41.90 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $123.84 | n/a | 3 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.45 | n/a | 2 | Dec 1, 2014 |
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.86
Upside: -
Sutro Biopharma
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $29.55
Upside: +45.52%
Tango Therapeutics
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $30.14
Upside: +82.48%
Immunome
May 15, 2026
Maintained: Buy
Price Target: $40 → $33
Current: $19.40
Upside: +70.10%
Damora Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $46 → $51
Current: $22.57
Upside: +125.96%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $7 → $11
Current: $2.07
Upside: +431.40%
Adlai Nortye
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $10.16
Upside: +126.38%
BridgeBio Oncology Therapeutics
Mar 6, 2026
Reiterated: Buy
Price Target: $41
Current: $7.69
Upside: +433.16%
Relmada Therapeutics
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $6.45
Upside: +24.03%
Agios Pharmaceuticals
Dec 25, 2025
Maintained: Buy
Price Target: $34 → $40
Current: $36.20
Upside: +10.50%
Nov 19, 2025
Maintained: Buy
Price Target: $24 → $40
Current: $23.77
Upside: +68.28%
Nov 17, 2025
Maintained: Buy
Price Target: $70 → $97
Current: $95.93
Upside: +1.12%
Nov 17, 2025
Maintained: Buy
Price Target: $140 → $149
Current: $123.53
Upside: +20.62%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $38.01
Upside: +31.56%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $4.53
Upside: +231.13%
Oct 21, 2025
Upgraded: Buy
Price Target: $38 → $48
Current: $53.23
Upside: -9.83%
Oct 21, 2025
Maintained: Hold
Price Target: $30 → $33
Current: $36.29
Upside: -9.07%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $18.48
Upside: -
Aug 13, 2025
Maintained: Buy
Price Target: $33
Current: $4.22
Upside: +681.99%
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $17.83
Upside: -32.70%
Aug 11, 2025
Maintained: Hold
Price Target: $3
Current: $2.51
Upside: +19.52%
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $275.34
Upside: +25.30%
Aug 7, 2025
Maintained: Hold
Price Target: $9
Current: $8.03
Upside: +12.08%
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $3.79
Upside: +31.93%
Aug 5, 2025
Maintained: Buy
Price Target: $18.00
Current: $9.81
Upside: +83.49%
Jul 30, 2025
Maintained: Buy
Price Target: $96 → $103
Current: $107.53
Upside: -4.21%
Feb 26, 2025
Maintained: Buy
Price Target: n/a
Current: $142.94
Upside: n/a
Dec 10, 2024
Maintained: Buy
Price Target: n/a
Current: $64.43
Upside: n/a
Feb 7, 2023
Maintained: Buy
Price Target: $67 → $25
Current: $4.40
Upside: n/a
Feb 7, 2023
Maintained: Hold
Price Target: $20 → $15
Current: $21.66
Upside: n/a
Mar 21, 2022
Maintained: Buy
Price Target: n/a
Current: $7.51
Upside: n/a
May 7, 2021
Maintained: Hold
Price Target: $10
Current: $7.67
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Maintained: Hold
Price Target: $23
Current: $108.26
Upside: n/a
Jul 14, 2017
Maintained: Hold
Price Target: $16 → $8
Current: $9.76
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $0.6508
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.04
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $41.90
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $123.84
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $13.45
Upside: n/a